Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S2213-8587(21)00111-X | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Establishment of a nomogram that predicts the risk of heart failure in hemodialysis patients.
Am Heart J Plus
January 2025
YAN'AN Hospital of Kunming City, Kunming 650051, China.
Chronic kidney disease (CKD) is expected to become the fifth leading cause of death globally by 2040. Cardiovascular disease (CVD), particularly heart failure (HF), is a severe complication in CKD patients on hemodialysis. This study aimed to develop a nomogram to predict the risk of heart failure hospitalization in hemodialysis patients, providing a valuable tool for clinical decision-making.
View Article and Find Full Text PDFPredictors of sepsis in trauma patients: a National Trauma Data Bank analysis.
Front Med (Lausanne)
December 2024
Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Background: Trauma remains a global health issue being one of the leading causes of death worldwide. Sepsis and infections are common complications contributing to mortality, emphasizing the need to understand factors leading to such complications following trauma.
Aim: This study aimed to identify risk factors associated with post-trauma sepsis using data from the National Trauma Data Bank (NTDB).
Association between asthma and cardiovascular disease: evidence from the national health and nutrition examination survey 1999-2018.
Front Cardiovasc Med
December 2024
Department of Cardiovascular Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China.
Background: Cardiovascular disease(CVD) remains a significant global challenge. Asthma, which is characterized by airway hyperresponsiveness and reversible and limited airflow, plays an important role in cardiovascular diseases. This study aimed to investigate the association between asthma and CVD.
View Article and Find Full Text PDFβ-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress.
Front Pharmacol
December 2024
Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Bialystok, Poland.
The growing burden of metabolic disorders manifested by hypertension, type 2 diabetes mellitus, hyperlipidemia, obesity and non-alcoholic fatty liver disease presents a significant global health challenge by contributing to cardiovascular diseases and high mortality rates. Β-blockers are among the most widely used drugs in the treatment of hypertension and acute cardiovascular events. In addition to blocking the receptor sites for catecholamines, third-generation β-blockers with associated vasodilating properties, such as carvedilol and nebivolol, provide a broad spectrum of metabolic effects, including anti-inflammatory and antioxidant properties and a favorable impact on glucose and lipid metabolism.
View Article and Find Full Text PDFLong-Term Remission Rate of Type 2 Diabetes Following Bariatric Surgery: A Retrospective Cohort Study in Adult Patients in Riyadh, Saudi Arabia.
Cureus
January 2025
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Introduction Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder that poses significant health and economic burdens, particularly in regions like Saudi Arabia where prevalence rates are among the highest globally. Bariatric surgery has emerged as a promising intervention, not only for weight reduction but also for inducing diabetes remission. However, while the short-term benefits of the procedure are well documented, long-term outcomes remain under-explored, especially in Saudi populations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!